We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.
- Authors
Griesel, Rulan; Maartens, Gary; Chirehwa, Maxwell; Sokhela, Simiso; Akpomiemie, Godspower; Moorhouse, Michelle; Venter, Francois; Sinxadi, Phumla
- Abstract
A correction for the article "CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz" is presented, which is published in the August 2020 issue of the periodical.
- Subjects
EFAVIRENZ; HIV infections; DRUG efficacy; CYTOCHROME P-450; ANTIRETROVIRAL agents; WEIGHT gain; GENOTYPES; EVALUATION
- Publication
Clinical Infectious Diseases, 2022, Vol 74, Issue 4, p755
- ISSN
1058-4838
- Publication type
Correction Notice
- DOI
10.1093/cid/ciab804